10-Q · August 6, 2025
Trulieve reported essentially flat Q2 revenue of $302,086,000 (Q2 2025 vs $303,442,000 Q2 2024) with slight gross profit expansion to $182,926,000. Operating income improved to $52,634,000 but the company recorded a…
Earnings analysis · 10-Q
Filed May 7, 2026 · Our reading of the company's report
The latest report
Trulieve Cannabis Corp. reported Q1 2026 results with revenues of $286.8 million, down 4% from Q1 2025’s $297.8 million, and a GAAP EPS of $0.02, marking a net income of $2.3 million, compared to a net loss of $33.8…
Trulieve Cannabis Corp. reported Q1 2026 results with revenues of $286.8 million, down 4% from Q1 2025’s $297.8 million, and a GAAP EPS of $0.02, marking a net income of $2.3 million, compared to a net loss of $33.8 million in the prior year. The company saw reduced operating and administrative expenses, while wholesale revenue saw an uptick, though retail revenue lagged behind due to price compression. Looking forward, operational stability is expected, bolstered by cash reserves exceeding $352 million.
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
Where each $100 of revenue went in this report.
Cost of sales, operating expenses, and what remained. Figures are rounded to whole dollars.
The business segments reported by the company.
Shares of the segments disclosed in this filing, largest first.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Q1 2026 revenue was $286.8 million, a smaller drop of 4% from $297.8 million in Q1 2025.
Net income for the quarter reached $2.3 million compared to a loss of $33.8 million in Q1 2025.
Operating cash flow increased to $55.7 million, rising from $51.1 million year-over-year.
Total expenses dropped by 10%, from $149.9 million in Q1 2025 to $134.4 million in Q1 2026.
Wholesale and other revenue increased by $5.8 million, partially offsetting the drop in retail revenues.
As of March 31, 2026, cash and cash equivalents were reported at $352.9 million.
Retail revenue decreased by $16.8 million, attributed to ongoing price compression.
Provision for income taxes decreased by $30.6 million due to previous IRC Section 280E impacts no longer being applicable.
The adult-use cannabis market remains illegal federally, posing ongoing operational risks.
Outlook deferred to earnings press release / call.
Trulieve reported essentially flat Q2 revenue of $302,086,000 (Q2 2025 vs $303,442,000 Q2 2024) with slight gross profit expansion to $182,926,000. Operating income improved to $52,634,000 but the company recorded a…
Trulieve reported strong top-line growth: Q3 revenue rose to $300,793,000 (Q3 2021: $224,092,000) and nine‑month revenue reached $937,612,000 (nine months 2021: $633,037,000). Despite revenue growth, margins and…
Trulieve reported strong top-line growth in Q1: revenue rose to $193,823,000 from $96,057,000 in Q1 2020 (+~101.8%), driving operating income of $72,563,000 (vs $42,512,000). Cash generation improved materially with net…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.